CraigSauterMD

PubMed

• 28 citations
  Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma.
  Ana Alarcon Tomas, Joshua A Fein, Shalev Fried, Jessica R Flynn, Sean M Devlin
  Leukemia. 2023-01-01
• 235 citations
  Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant
  Ying Taur, Katharine Z. Coyte, Jonas Schluter, Elizabeth Robilotti, Cesar J. Figueroa
  Science Translational Medicine. 2018-09-26
• 171 citations
  Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes
  Juliet N. Barker, Ekaterina Doubrovina, Craig S. Sauter, Jennifer Jaroscak, Miguel Perales
  Blood. 2010-12-02

Journal Articles

• Strategies to Improve Outcomes of Autologous Hematopoietic Cell Transplant in Lymphoma  
  Parastoo B Dahi, Hillard M Lazarus, Sergio A Giralt, Craig S Sauter, Nature

Abstracts/Posters

• Hematological Count Recovery in Patients Undergoing Treatment with Chimeric Antigen Receptor T Cells (CAR T)
  Craig S. Sauter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• MSKCC Early Experience Using Radiotherapy As a Bridging Strategy for Relapsed Diffuse Large B Cell Lymphoma before CD19 CAR T Therapy
  Craig S. Sauter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Early Experience Using Radiotherapy As a Salvage Treatment for Relapsed or Refractory Non-Hodgkin Lymphomas Following CD19 Chimeric Antigen Receptor Modified T-Cell Th...
  Craig S. Sauter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Contemporary Outcomes in HTLV-1-Associated Adult T-Cell Leukemia/Lymphoma: Single-Institution Experience
  Craig S. Sauter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Retrospective Analysis of Gemcitabine and Oxaliplatin (GemOx)-Based Treatment in Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma
  Craig S. Sauter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Highly Favorable Outcomes with Salvage Radiation Therapy Followed By Autologous Transplant in Relapsed and Refractory DLBCL Patients with Minimal or No Response to Sal...
  Craig S. Sauter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Allogeneic Stem Cell Transplantation (alloHSCT) for Chronic Lymphocytic Leukemia (CLL) in the Era of Novel Agents
  Craig S. Sauter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• A Phase II, Multicenter Study of High Dose Chemotherapy with Autologous Stem Cell Transplant Followed By Maintenance Therapy with Romidepsin for T-Cell Lymphoma
  Craig S. Sauter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Impact and Safety of Chimeric Antigen Receptor T Cell Therapy in Vulnerable Older Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
  Craig S. Sauter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Comparing Gradings of Immune Effector Cells Toxicities: Application of Astct Consensus Grading System and Implications for Clinical Management
  Craig S. Sauter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Long-Term Follow-up Confirms Durability of Single-Agent Brentuximab Vedotin As Pre-Transplant Salvage for Classical Hodgkin Lymphoma
  Craig S. Sauter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Easix and Modified-Easix Are Early Predictors of Severe Cytokine Release Syndrome and Neurotoxicity in Patients Treated with Chimeric Antigen Receptor T Cells
  Craig S. Sauter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Delayed Neutrophil Engraftment in Patients Receiving Daratumumab As Part of Their First Induction Regimen for Multiple Myeloma
  Craig S. Sauter, 61st Annual American Society of Hematology Meeting, 61st Annual American Society of Hematology Meeting - Orlando, FL, 12/9/2019
• Join now to see all

Lectures

• A Simple Geriatric Vulnerability Index for Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Double-Unit Cord Blood (CB) Transplantation with Haplo-Identical CD34+ Cells (haplo-dCBT) May Speed Neutrophil Recovery Although Successful Bridging Is Contingent on C... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• The Prognostic Calculator Easix Predicts Acute Gvhd, Non-Relapse Mortality and Overall Survival in Adult Patients Undergoing Reduced Intensity Conditioning Allogeneic HCT 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018